Abstract
Cancer is a collection of ailments that severely affect the cellular metabolism established due to anomalous signaling mechanisms including cell proliferation, angiogenesis, and metastasis. Biogenic nanoparticles due to their efficacy, cost-effectiveness, and green nature provide an alternate paradigm to cancer theranostics. In this chapter we will discuss the underlying mechanisms via which biogenic metal nanoparticles exert their anticancer action. Foreseeing the challenges, we expect that biogenic metal nanoparticles can be developed as prospective cancer theranostic agents in the near future.
| Original language | English |
|---|---|
| Title of host publication | Biogenic Nanoparticles for Cancer Theranostics |
| Publisher | Elsevier |
| Pages | 229-248 |
| Number of pages | 20 |
| ISBN (Electronic) | 9780128214671 |
| DOIs | |
| State | Published - 1 Jan 2021 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biogenic nanoparticles
- Cancer theranostics
- Green synthesis
- Metal nanoparticles
- Nanomedicines
- Phytosynthesis
ASJC Scopus subject areas
- General Engineering
- General Materials Science
Fingerprint
Dive into the research topics of 'Mechanisms underlying the anticancer applications of biosynthesized nanoparticles'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver